Increased leukotriene B4 and 8-isoprostane in exhaled breath condensate of patients with exacerbations of COPD

Thorax. 2003 Apr;58(4):294-8. doi: 10.1136/thorax.58.4.294.

Abstract

Background: Exacerbations are an important feature of chronic obstructive pulmonary disease (COPD), accounting for a large proportion of health care costs. They are associated with increased airway inflammation and oxidative stress.

Methods: Concentrations of leukotriene B4 (LTB4), a marker of inflammation, and 8-isoprostane, a marker of oxidative stress, were measured in the exhaled breath condensate of 21 patients (11 M) with COPD during an exacerbation and 2 weeks after treatment with antibiotics. In 12 patients who had no further exacerbations these markers were also measured after 2 months.

Results: LTB4 concentrations were raised during the COPD exacerbation (mean (SE) 15.8 (1.1) pg/ml and fell after treatment with antibiotics to 9.9 (0.9) pg/ml (p<0.0001). In 12 patients the level of LTB4 fell further from 10.6 (1.1) pg/ml to 8.5 (0.8) pg/ml (p<0.005) after 2 months. In 12 normal age matched subjects the LTB4 levels were 7.7 (0.5) pg/ml. Concentrations of 8-isoprostane were also increased during the exacerbation (13.0 (0.9) pg/ml) and fell after antibiotic treatment to 9.0 (0.6) pg/ml (p<0.0001). In 12 patients there was a further fall from 9.3 (0.7) pg/ml to 6.0 (0.7) pg/ml (p<0.001) after 2 months compared with normal subjects (6.2 (0.4) pg/ml).

Conclusions: Non-invasive markers of inflammation and oxidative stress are increased during an infective exacerbation of COPD and only slowly recover after treatment with antibiotics.

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use
  • Adrenergic beta-2 Receptor Antagonists
  • Adrenergic beta-Agonists / therapeutic use
  • Aged
  • Anti-Bacterial Agents / therapeutic use
  • Biomarkers / analysis
  • Breath Tests
  • Dinoprost* / analogs & derivatives*
  • F2-Isoprostanes / analysis*
  • Female
  • Forced Expiratory Volume / physiology
  • Humans
  • Leukotriene B4 / analysis*
  • Male
  • Oxidative Stress / physiology
  • Pneumonia / metabolism
  • Pulmonary Disease, Chronic Obstructive / drug therapy
  • Pulmonary Disease, Chronic Obstructive / metabolism*
  • Vital Capacity / physiology

Substances

  • Adrenal Cortex Hormones
  • Adrenergic beta-2 Receptor Antagonists
  • Adrenergic beta-Agonists
  • Anti-Bacterial Agents
  • Biomarkers
  • F2-Isoprostanes
  • Leukotriene B4
  • 8-epi-prostaglandin F2alpha
  • Dinoprost